Yutong Ma

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Combination Therapy

Polycystic Ovary Syndrome

Advanced Non Small Cell Lung Cancer

Circulating Tumor

Top Venues

Cancer communications (London, England)

OncoTargets and therapy

Clinical Medicine Insights. Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Buhai Wang, Yaqin Fan, Liying Zhang, Liqin Liu, Yutong Ma, Xiaosong Ma, Yuxiang Huang, Yinxia Wu, Yichen Liang, Yang Xu, Xue Wu
Evaluation of Pembrolizumab Monotherapy Efficacy in Advanced Non-Small-Cell Lung Cancer by Serial Monitoring of Circulating Tumor DNA Using Next-Generation Sequencing. Clinical Medicine Insights. Oncology 16 (2022)
Yue Wang, Shuang Tan, Evenki Pan, Yutong Ma, Xue Wu, Zhe Yu, Kui Jiang
An Effective Hormonal Therapy for a Patient with Estrogen Receptor 1 ( ESR1 )-Amplified Metastatic Ovarian Cancer: A Case Report. OncoTargets and therapy 15 (2022)
Dafu Yang, Dan Li, Zhaoxia Dai, Yutong Ma, Qiuxiang Ou, Xue Wu, Saiqiong Cui
Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors. Cancer communications (London, England) 41 (2) (2021)
Yanshuo Cao, Yutong Ma, Jiangyuan Yu, Yu Sun, Tingting Sun, Yang Shao, Jie Li, Lin Shen, Ming Lu
Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide-induced high tumor mutational burden. Cancer communications (London, England) 40 (12) (2020)